Same Indication

Metformin vs Rituximab

Metformin vs Rituximab: Overview

This comparison examines the pharmacological differences between Metformin and Rituximab.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Metformin β€” 4-9 hours; Rituximab β€” 22 days.

Chemical Properties

Molecular Formula: Metformin β€” C4H11N5.

Molecular Weight: Metformin β€” 129.1640 g/mol.

Type: Metformin β€” Small molecule; Rituximab β€” Antibody.